Alzheimer’s Disease Symptoms Reversed in Mice
A nearly 13-year-old skin cancer drug rapidly alleviates molecular signs of Alzheimer’s disease and improves brain function, according to the results of a new mouse study being hailed as extremely promising. Early-stage human clinical trials could begin within months.
In the study, published online by Science, researchers from Case Western Reserve University in Cleveland and colleagues used mice genetically engineered to exhibit some of the symptoms of Alzheimer’s. Most notably, the mice produced amyloid beta peptidesâ€”toxic protein fragments that gum up neurons and lead to cell deathâ€”and showed signs of forgetfulness. The Case Western team fed the drug bexarotene to the demented mice, and with just a single dose it lowered the most toxic form of the amyloid beta peptide by 25 percent within six hours, an effect that lasted for up to three days. Mice that were cognitively impaired by the amyloid buildup resumed normal behaviors after 72 hours: They began to crinkle toilet paper placed nearby to make nests, a skill lost as amyloid increased in their brains.